Jounce Therapeutics
Why Robinhood?
You can watch JNCE and buy or sell other stocks, ETFs, and their options commission-free!About JNCE
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors.
JNCE Key Statistics
Stock Snapshot
As of today, Jounce Therapeutics(JNCE) shares are valued at $1.88. The company's market cap stands at 98.95M, with a P/E ratio of -1.91.
On 2026-03-06, Jounce Therapeutics(JNCE) stock opened at —, reached a high of —, and a low of —.
The Jounce Therapeutics(JNCE)'s current trading volume is 0, compared to an average daily volume of 2.01M.
During the past year, Jounce Therapeutics(JNCE) stock moved between $0.58 at its lowest and $5.87 at its peak.
During the past year, Jounce Therapeutics(JNCE) stock moved between $0.58 at its lowest and $5.87 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.